Paige Answers Call to Better Identify Breast Cancer Patients with Low Expression of HER2
Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low tumors that have been shown to benefit from targeted treatments Paige now holds eight CE and UKCA marks in its portfolio NEW … [Read more…]
